← Eichor
Study identifier: NCT06107517 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Reducing Delirium After CABG Surgery With Early Activation and Sleep-Promoting Routines

Condition: Delirium, Postoperative  ·  Sponsor: National University Hospital, Singapore

PhaseNA
Planned participants300
Who can joinAll sexes, 21 Years to 99 Years
Healthy volunteersNo

About this study

The goal of this randomized-controlled trial (RCT) is to compare the effectiveness of the DREAMS-OT intervention with standard care in reducing post-Coronary Artery Bypass Graft (CABG) surgery delirium in patients undergoing CABG surgery. The aims of the study are: 1. To determine if early and intensive OT will lower the incidence of post-op delirium in CABG patients compared to standard are. 2. To determine the cost effectiveness of the DREAMS-OT intervention. The study team will compare intervention group and standard care group (control group) to see if there is a reduction in the incidence of delirium in patients 5 days post-CABG.

This description comes directly from the study's public registry record.

Talk to the study team

Megan HL Tan  ·  +65-96280613  ·  megan_huei_lin_tan@nuhs.edu.sg

Michell KS Low  ·  +65 83164092  ·  michell_kai_sian_low@nuhs.edu.sg

Always discuss trial participation with your own doctor first.

Locations (1)

National University HospitalSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06107517